Test Price
2,800 AED✅ Home Collection Available
SLC52A2 Gene Brown‑Vialetto‑Van Laere Syndrome Type 2 Genetic Test in UAE | 2800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- ✔️Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- ✔️Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✔️Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed specialists.
- ✔️Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS‑based assay sequences the full coding region of the SLC52A2 gene, providing the definitive molecular diagnosis for Brown‑Vialetto‑Van Laere syndrome type 2 – a treatable riboflavin transporter deficiency that causes progressive sensorineural hearing loss, bulbar palsy, and respiratory failure if untreated.
| Feature | Our Test | Closest Alternative (Whole Exome) |
|---|---|---|
| Precision | Targeted SLC52A2 full‑gene analysis with >99.9% analytical sensitivity | Broad exome capture; lower coverage depth on this gene, risk of missing CNVs |
| Methodology | Illumina® NGS with Sanger confirmation of all pathogenic variants | Whole Exome Sequencing (WES), often without targeted confirmation |
| Turnaround | 3–4 Weeks | 6–12 Weeks |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that this test provides a precise molecular answer for Brown‑Vialetto‑Van Laere syndrome type 2. The result should be interpreted alongside full clinical assessment by a multidisciplinary team including neurology, ENT, and genetic counselling. Always continue any prescribed treatments and never modify them without your doctor’s guidance.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor.
A genetic diagnosis does not replace ongoing clinical care. Continue all treatments as directed by your physician.
🚨 Exclusion Criteria & Emergency Red Flags
- Not suitable for patients in acute respiratory distress or requiring immediate intensive care – prioritize emergency management.
- This test is not a substitute for urgent neurological assessment if acute bulbar palsy, stridor, or cyanosis is present.
- Seek emergency care immediately if you experience sudden worsening of swallowing difficulty, noisy breathing, or respiratory distress.
Patient FAQ & Clinical Guidance
1. What exactly does the SLC52A2 gene test detect?
This genetic test definitively identifies pathogenic variants in the SLC52A2 gene that cause Brown‑Vialetto‑Van Laere syndrome type 2, enabling a precise molecular diagnosis and guiding high‑dose riboflavin therapy.
2. How is the sample collected and when will I receive results?
A trained DHA‑licensed phlebotomist collects a small blood sample, extracted DNA, or a single blood drop on an FTA card at your home via our VIP Mobile Phlebotomy service. Results are securely delivered within 3 to 4 weeks through our patient portal.
3. Is this genetic test covered by my UAE health insurance?
We provide direct insurance billing verification via WhatsApp at +971 54 548 8731. Most UAE insurers cover medically indicated genetic testing. We assist with pre‑authorization to minimize out‑of‑pocket expenses.
UAE Regulatory & Data Privacy Adherence
This test is performed under the strict privacy framework of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted and handled in compliance with DHA standards.
Clinical & Logistical Metadata
| Test Name | SLC52A2 Gene Sequencing (Brown‑Vialetto‑Van Laere Syndrome Type 2) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Extracted DNA; also FTA card acceptable. VIP Mobile Phlebotomy & Cold-Chain Home Collection available daily 8 AM–11 PM. |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) + Sanger Confirmation (Illumina®) |
| ICD-10-CM Code | G31.89, G60.0 |
| LOINC Code | 103527-5 |
| DHA Facility License & Laboratory Address | License: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians